Related Experiment Video
Updated: Jan 5, 2026
12:58
A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
9.3K
Recent developments in the management of recurrent Clostridioides difficile infection
Rafael Mendo-Lopez1, Javier Villafuerte-Gálvez1, Nicole White2
1Department of Medicine, Division of Gastroenterology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Anaerobe
|October 14, 2019
Summary
Recurrent Clostridioides difficile infection (rCDI) poses significant challenges. This review covers updated management, prevention, and novel treatments like bacteriotherapy for this persistent infection.
Area of Science:
- Infectious Diseases
- Microbiology
- Gastroenterology
Background:
- Clostridioides difficile infection (CDI) is a major cause of hospital-acquired infections.
- Recurrent C. difficile infection (rCDI) presents significant morbidity, mortality, and economic burden.
- Current treatment guidelines lack comprehensive preventive and therapeutic strategies for rCDI.
Purpose of the Study:
- To review key updates in the management of rCDI.
- To highlight current preventive measures for rCDI.
- To discuss ongoing research into novel treatment strategies, including bacteriotherapy.
Main Methods:
- Mini-review of existing literature and clinical guidelines.
- Analysis of recent advancements in C. difficile treatment and prevention.
- Focus on emerging therapies such as bacteriotherapy.
Main Results:
- Despite updated guidelines, effective rCDI prevention and treatment remain challenging.
- Novel therapeutic approaches are under development to address rCDI.
- Bacteriotherapy shows promise as a targeted treatment for rCDI.
Conclusions:
- rCDI necessitates continued research into effective management and prevention.
- Novel therapies, particularly bacteriotherapy, offer potential for improved rCDI outcomes.
- A multi-faceted approach combining prevention and targeted treatments is crucial for controlling rCDI.
Related Concept Videos
01:29Inflammatory Bowel Disease IV: Pharmacological Management
420
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
420
01:21Inflammatory Bowel Disease V: Surgical Management
415
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
415
01:17Drugs for Treatment of Diarrhea-Predominant IBS
584
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
584
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
596
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
596
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
606
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
606
01:26Peptic Ulcer Disease IV: Management
392
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
392